InvestorsHub Logo

BottomBounce

10/29/19 1:13 PM

#145 RE: pearsby09 #122

Sci-B-Vac data is in December. That's the drug beating $GSK's Engerix-B

The infection prevention rate for $VBIV 91.4% for Sci-B-Vac

The infection prevention rate for $GSK 76.5% for Engerix-B